Cathie Wood Verve Therapeutics, Inc. Transaction History

Ark Investment Management LLC

$14 Billion
Q1 2024

A detailed history of Cathie Wood (Ark Investment Management LLC) transactions in Verve Therapeutics, Inc. stock. As of the latest transaction made, Ark Investment Management LLC holds 6,040,476 shares of VERV stock, worth $36.1 Million. This represents 0.57% of its overall portfolio holdings.

Number of Shares

6,040,476

Previous 7,025,116 14.02%

Holding current value

$36.1 Million

Previous $97.9 Million 18.09%

% of portfolio

0.57%

Previous 0.59%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 18, 2024	SELL	$10.81 - $17.96 $10.6 Million - $17.7 Million	-984,640 Reduced 14.02%	6,040,476 $80.2 Million
Q4 2023 Jan 17, 2024	BUY	$8.84 - $18.7 $16.1 Million - $34.1 Million	1,824,549 Added 35.08%	7,025,116 $97.9 Million
Q3 2023 Oct 18, 2023	BUY	$11.42 - $20.82 $567,756 - $1.04 Million	49,716 Added 0.97%	5,200,567 $69 Million
Q2 2023 Jul 10, 2023	BUY	$13.34 - $19.9 $8.92 Million - $13.3 Million	668,760 Added 14.92%	5,150,851 $96.6 Million
Q1 2023 Apr 17, 2023	BUY	$14.3 - $24.01 $1.66 Million - $2.79 Million	116,261 Added 2.66%	4,482,091 $64.6 Million

Q4 2022 Jan 24, 2023	BUY	$17.85 - $40.7 $17.3 Million - $39.6 Million	971,971 Added 28.64%	4,365,830 $0
Q3 2022 Oct 17, 2022	BUY	$15.63 - $41.49 $21.3 Million - $56.4 Million	1,359,735 Added 66.85%	3,393,859 $117 Million
Q2 2022 Jul 11, 2022	BUY	$11.14 - $23.17 $3.87 Million - $8.04 Million	347,179 Added 20.58%	2,034,124 $30.8 Million
Q1 2022 Apr 19, 2022	BUY	$20.92 - $39.36 $6.01 Million - $11.3 Million	287,400 Added 20.54%	1,686,945 $38.5 Million
Q4 2021 Jan 28, 2022	BUY	$31.94 - $54.82 $4.21 Million - $7.23 Million	131,840 Added 10.4%	1,399,545 $51.6 Million
Q3 2021 Nov 12, 2021	BUY	$46.0 - $73.99 $33.1 Million - $53.2 Million	719,316 Added 131.17%	1,267,705 $59.6 Million
Q2 2021 Aug 05, 2021	BUY	$31.92 - $60.25 $17.5 Million - $33 Million	548,389 New	548,389 $33 Million

Others Institutions Holding VERV

# of Institutions

168

Shares Held

78.3M

Call Options Held

125K

Put Options Held

185K

View Full List

About Verve Therapeutics, Inc.

Ticker VERV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,942,300
Market Cap $358M
Description
Verve Therapeutics, Inc., a genetic medicines company, engages in developing gene editing medicines for patients to treat cardiovascular diseases. Its lead product candidate is VERVE-101, a single-course gene editing treatment that permanently turns off the PCSK9 gene in the liver. The company also engages in the development of ANGPTL3 program t...

More about VERV

Track Cathie Wood's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ark Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ark Investment Management LLC and Cathie Wood with notifications on news.

Account